Development of interim patient‐reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2036|269-2813|10|1200-1210

ISSN: 0269-2813

Source: ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.269-2813, Iss.10, 2015-11, pp. : 1200-1210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract